Well-differentiated thyroid cancer and robotic transaxillary surgery at a North American institution
| Autor: | Hosam Shalaby, Daniah Bu Ali, Khuzema Mohsin, Kareem Ibraheem, Emad Kandil, Mahmoud Farag, Sang-Wook Kang, Meghan E. Garstka |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty Operative Time Blood Loss Surgical Thyroid Gland 03 medical and health sciences Postoperative Complications 0302 clinical medicine Robotic Surgical Procedures medicine Humans Robotic surgery Prospective Studies Thyroid Neoplasms Lymph node Thyroid cancer Aged Retrospective Studies Academic Medical Centers business.industry Thyroid Margins of Excision New Orleans Retrospective cohort study Perioperative Length of Stay Middle Aged medicine.disease Surgery Treatment Outcome medicine.anatomical_structure 030220 oncology & carcinogenesis Thyroidectomy Feasibility Studies Lymph Node Excision Female 030211 gastroenterology & hepatology Lymph Neoplasm Recurrence Local business Complication |
| Zdroj: | Journal of Surgical Research. 228:170-178 |
| ISSN: | 0022-4804 |
| DOI: | 10.1016/j.jss.2018.03.030 |
| Popis: | Background Recent studies from Asia have reported the safety and feasibility of robotic-assisted thyroid surgery. In the United States, several small series and case reports have been published, mostly regarding treatment of benign disease. The aim of our study is to report the safety and feasibility of robotic surgery for well-differentiated thyroid cancer patients at a North American institution. Materials and Methods We performed a retrospective cohort study using a prospectively collected single-center clinical database at Tulane University Medical Center. We included all well-differentiated thyroid cancer patients who underwent robotic-assisted or conventional cervical approach thyroid surgery with or without lymph node dissections at our institution from January 2015 to June 2017. Patient demographics and perioperative data were collected and analyzed. Results A total of 144 surgeries for thyroid cancer were performed; 35 (24.3%) were robotic-assisted. There were no significant differences in estimated blood loss, operative times, complication rates, specimen sizes, positive microscopic margins, number of lymph nodes removed with associated lymph node dissections, patient follow-up duration, or clinical recurrence rates between the two groups. Overall length of stay was shorter for robotic-assisted surgery, at 0.6 ± 0.9 d, versus 1.1 ± 1.2 d for conventional open surgery (P = 0.009). For robotic-assisted surgery, 19 patients (54.3%) were discharged on the day of procedure, and only one patient was admitted as inpatient to the hospital (2.9%). Conclusions Robot-assisted thyroid surgery is a safe, feasible, and oncologically sound approach for a select group of well-differentiated thyroid cancer patients. However, long-term studies are needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect